Open Access

Dual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation

  • Authors:
    • Yung‑Luen Yu
    • Giou‑Teng Yiang
    • Pei‑Lun Chou
    • Hsu‑Hung Tseng
    • Tsai‑Kun Wu
    • Yu‑Ting Hung
    • Pei‑Shiuan Lin
    • Shu‑Yu Lin
    • Hsiao‑Chun Liu
    • Wei‑Jung Chang
    • Chyou‑Wei Wei
  • View Affiliations

  • Published online on: March 28, 2014     https://doi.org/10.3892/mmr.2014.2085
  • Pages: 2077-2084
  • Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Acetaminophen (APAP), is a safe analgesic and antipyretic drug at therapeutic dose, and is widely used in the clinic. However, high doses of APAP can induce hepatotoxicity and nephrotoxicity. Most studies have focused on high‑dose APAP‑induced acute liver and kidney injury. So far, few studies have investigated the effects of the therapeutic dose (1/10 of the high dose) or of the low dose (1/100 of the high dose) of APAP on the cells. The aim of this study was to investigate the cellular effects of therapeutic- or low‑dose APAP treatment on hepatoma cells and kidney fibroblasts. As expected, high‑dose APAP treatment inhibited while therapeutic and low‑dose treatment did not inhibit cell survival of kidney tubular epithelial cells. In addition, therapeutic-dose treatment induced an increase in the H2O2 level, activated the caspase‑9/‑3 cascade, and induced cell apoptosis of hepatoma cells. Notably, APAP promoted fibroblast proliferation, even at low doses. This study demonstrates that different cellular effects are exerted upon treatment with different APAP concentrations. Our results indicate that treatment with the therapeutic dose of APAP may exert an antitumor activity on hepatoma, while low‑dose treatment may be harmful for patients with fibrosis, since it may cause proliferation of fibroblasts.
View Figures
View References

Related Articles

Journal Cover

June-2014
Volume 9 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu YL, Yiang GT, Chou PL, Tseng HH, Wu TK, Hung YT, Lin PS, Lin SY, Liu HC, Chang WJ, Chang WJ, et al: Dual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation. Mol Med Rep 9: 2077-2084, 2014
APA
Yu, Y., Yiang, G., Chou, P., Tseng, H., Wu, T., Hung, Y. ... Wei, C. (2014). Dual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation. Molecular Medicine Reports, 9, 2077-2084. https://doi.org/10.3892/mmr.2014.2085
MLA
Yu, Y., Yiang, G., Chou, P., Tseng, H., Wu, T., Hung, Y., Lin, P., Lin, S., Liu, H., Chang, W., Wei, C."Dual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation". Molecular Medicine Reports 9.6 (2014): 2077-2084.
Chicago
Yu, Y., Yiang, G., Chou, P., Tseng, H., Wu, T., Hung, Y., Lin, P., Lin, S., Liu, H., Chang, W., Wei, C."Dual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation". Molecular Medicine Reports 9, no. 6 (2014): 2077-2084. https://doi.org/10.3892/mmr.2014.2085